PMID: 2117174Jan 1, 1990Paper

Management of asthma and chronic airflow limitation: are methylxanthines obsolete?

Lung
M T Newhouse, A Lam

Abstract

The widespread popularity of methylxanthine derivatives should be reassessed in light of current evidence. These drugs are relatively weak bronchodilators, respiratory muscle stimulants and inotropic agents and adverse effects, sometimes life threatening, occur fairly frequently. In contrast, beta-2 adrenergic and anticholinergic bronchodilator aerosols used in asthma or chronic obstructive lung disease, and the prophylactic anti-inflammatory aerosols of corticosteroids and cromolyn provide a spectrum of therapeutic choices which address both the inflammatory and bronchoconstrictor components of acute and chronic airflow limitation. Aerosol bronchodilators, in general, are more potent, are virtually free of important side effects, and do not require costly serum level monitoring. Adrenoceptor agonists, together with inhaled steroids, should be considered first-line drugs of choice in managing patients with reversible airflow obstruction associated with asthma or COPD, while methylxanthines should be relegated to the position of third or fourth line drugs, if they are to be used at all. If they are, they should be used with great caution and close patient supervision and, even then, only if benefit, over and above the aerosol br...Continue Reading

References

Feb 16, 1978·The New England Journal of Medicine·J D WolfeM Simmons
Oct 1, 1988·The American Journal of Medicine·A K RoyR A Levine
Mar 18, 1988·JAMA : the Journal of the American Medical Association·B Littenberg
Mar 1, 1988·The American Review of Respiratory Disease·V R KongraguntaJ T Sharp
Jul 1, 1988·Clinical Pharmacology and Therapeutics·S M SirmansT H Self
Jan 16, 1986·The New England Journal of Medicine·B Littenberg, E H Gluck
Jan 1, 1987·The Journal of Allergy and Clinical Immunology·J P JoadM M Weinberger
Sep 25, 1982·British Medical Journal·M D MorganS J Williams
Jan 1, 1982·European Journal of Clinical Pharmacology·J BarclayG J Addis
Sep 1, 1981·The American Journal of Medicine·C Shim, M H Williams
Jun 1, 1980·Annals of Internal Medicine·M L EatonD E Niewoehner
Sep 1, 1980·Annals of Internal Medicine·C Shim, M H Williams

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.